Strategic Wealth Partners’s Definium Therapeutics DFTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10K Sell
263
-166
-39% -$7K ﹤0.01% 733
2026
Q2
$20.2K Buy
429
+263
+158% +$6.5K ﹤0.01% 745
2026
Q1
$3.14K Hold
166
– – ﹤0.01% 1111
2025
Q4
$2.22K Buy
+166
New +$2.05K ﹤0.01% 1186

Other funds holding DFTX

Strategic Wealth Partners's DFTX Position: Q3 2026 in Review

Strategic Wealth Partners reduced its Definium Therapeutics (DFTX) stake by 39% in Q3 2026, selling an estimated $7K and leaving 263 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #733.

Strategic Wealth Partners first reported a position in DFTX in Q4 2025 and has held it in 4 quarters since. The position peaked at $20.2K in Q2 2026. 349 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

  • Strategic Wealth Partners held 263 shares of Definium Therapeutics worth $10K as of Q3 2026.
  • Strategic Wealth Partners sold 166 Definium Therapeutics shares in Q3 2026, an estimated $7K.
  • Definium Therapeutics made up ﹤0.01% of Strategic Wealth Partners's portfolio in Q3 2026, its #733 holding.
  • Strategic Wealth Partners first reported a position in Definium Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • Strategic Wealth Partners's Definium Therapeutics position peaked at $20.2K in Q2 2026.
  • 349 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on Strategic Wealth Partners's 13F filing for Q3 2026, filed 13 Nov 2026.